| 000 | 01559 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512211022.0 | ||
| 264 | 0 | _c19831021 | |
| 008 | 198310s 0 0 eng d | ||
| 022 | _a0090-1229 | ||
| 024 | 7 |
_a10.1016/0090-1229(83)90103-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSirianni, M C | |
| 245 | 0 | 0 |
_aSevere combined immunodeficiencies, primary T-cell defects and DiGeorge syndrome in humans: characterization by monoclonal antibodies and natural killer cell activity. _h[electronic resource] |
| 260 |
_bClinical immunology and immunopathology _cSep 1983 |
||
| 300 |
_a361-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xanalysis |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 |
_aDiGeorge Syndrome _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xclassification |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeptide Fragments _xadministration & dosage |
| 650 | 0 | 4 |
_aT-Lymphocytes _xclassification |
| 650 | 0 | 4 | _aThymopentin |
| 650 | 0 | 4 |
_aThymopoietins _xadministration & dosage |
| 700 | 1 | _aBusinco, L | |
| 700 | 1 | _aSeminara, R | |
| 700 | 1 | _aAiuti, F | |
| 773 | 0 |
_tClinical immunology and immunopathology _gvol. 28 _gno. 3 _gp. 361-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-1229(83)90103-4 _zAvailable from publisher's website |
| 999 |
_c6349800 _d6349800 |
||